Cortical expression of nuclear factor kappaB after human brain contusion.
The aim of current study was to analyze the binding activity and the temporal and cellular expression of nuclear factor kappa B (NF-kappaB) in human contused brain. Eighteen contused brain samples were obtained from 17 patients undergoing surgery for brain contusions 5-80 h after trauma. NF-kappaB binding activity was detected by electrophoretic mobility shift assay (EMSA), and temporal and cellular expression of NF-kappaB subunits p65 and p50 was analyzed by immunohistochemistry. The results showed that a progressive upregulation of NF-kappaB activity occurred in the area surrounding the injured brain with the time from brain trauma to operation. The maximal expression of NF-kappaB was detected after 48 h postinjury. The expression of NF-kappaB p65 was mainly located at glial and vascular endothelial cells without expression at neurons. The expression of NF-kappaB p50 was mainly located at glial cells, a little at neurons and no expression at vascular endothelial cells. Within 24 h postinjury, both NF-kappaB p65 and p50 immunoreactivity was mainly observed in the nucleus of cells. After 24 h postinjury, NF-kappaB p65 labeling was found in the both nucleus and cytoplasm of glial and endothelial cells; otherwise, p50 labeling was primarily found in the nucleus of glial cells and in the nucleus, cytoplasm and process of neurons. It is concluded that NF-kappaB could be highly upregulated at human contused brain and the cellular pattern of p65 and p50 expression might be closely associated with the cell functions.
Hang
Chun-Hua
CH
Department of Neurosurgery, Jinling Hospital, School of Medicine, Nanjing University, 305 East Zhongshan Road, Nanjing 210002, Jiangsu Province, P.R. China. hang1965@public1.ptt.js.cn
Chen
Gang
G
Shi
Ji-Xin
JX
Zhang
Xin
X
Li
Jing-Song
JS
D000293:Adolescent; D000328:Adult; D001924:Brain Concussion / Q000378:metabolism* / Q000473:pathology; D002540:Cerebral Cortex / Q000378:metabolism* / Q000473:pathology; D024202:Electrophoretic Mobility Shift Assay / Q000379:methods; D005260:Female; D015870:Gene Expression / Q000502:physiology*; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D008297:Male; D008875:Middle Aged; D016328:NF-kappa B / Q000378:metabolism*; D021122:Protein Subunits / Q000378:metabolism; D013997:Time Factors
D016328:NF-kappa B; D021122:Protein Subunits